Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...

A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.

Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...

As more Americans are prescribed weight loss drugs like Ozempic and Wegovy following celebrity endorsements, people who depend on such medications have struggled to access them. Sarah Sostak, a ...

Ozempic breasts refer to changes in breast size or shape due to weight loss from GLP-1 drugs. Here’s how and why this side ...

Eli Lilly's Phase 3 study shows tirzepatide significantly cuts type 2 diabetes risk and supports 22.9% average weight loss in adults over three years.

The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, ...

This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...

Getting enough fiber in your diet is associated with improved digestion, better blood sugar control, and improved metabolism, ...